Zolpidem? For what?

Zolpidem: uses

Zolpidem is used to treat sleep problems ( insomnia ) . It may help we fall asleep faster, stay asleep longer, and reduce number of times we awaken during the night. Zolpidem belongs to a class of drugs called sedative/hypnotics. It acts on your brain to produce a calming effect.

Zolpidem: how to use

Read the Patient Information Leaflet provided by your pharmacist before we start using Zolpidem and each time you get a refill. If we have any questions regarding information, consult your doctor or pharmacist.

Take Zolpidem by mouth, usually once nightly immediately before bedtime on an empty stomach, or as directed by your doctor. Don't take it with food because effect of medication will be delayed.

Swallow Zolpidem whole. Do not crush, chew, or break Zolpidem. Doing so can destroy the long action of drug and may increase side effects.

Dosage is based on your medical condition, age, and response to therapy.

Although unlikely, Zolpidem can infrequently cause temporary memory loss. To avoid this effect, don't take a dose of Zolpidem unless you have time for a full night's sleep that lasts at least 7-8 hours. For example, do not take Zolpidem during an overnight plane flight of less than 8 hours.

Zolpidem may cause dependence, especially if it has been used regularly for an extended period of time, or if it has been used in high doses. In such cases, if you suddenly stop Zolpidem, withdrawal reactions may occur while use Zolpidem. Such reactions can include nausea, vomiting, flushing, stomach cramps, nervousness, or shakiness. Report any such reactions to your doctor immediately. When stopping extended, regular treatment with Zolpidem, gradually reducing dosage as directed will help prevent withdrawal reactions. Consult your doctor or pharmacist for more details.

Though it's very unlikely to occur, Zolpidem can also result in abnormal drug-seeking behavior ( addiction/habit-forming ) . Don't increase your dose, take it more frequently or use it for a longer period of time than prescribed. Properly stop the medication when so directed. This will lessen chances of becoming addicted.

When used for an extended period, Zolpidem mayn't work as well and may require different dosing. Talk with your doctor if this medication stops working well.

We may have trouble sleeping first few nights after we stop taking Zolpidem. This is called rebound insomnia and it's normal. It'll usually go away after 1-2 nights. If this effect continues, contact your doctor.

Inform your doctor if your condition persists or worsens after 7-10 days.

Zolpidem: side effects

Dizziness, lightheadedness, headache, upset stomach, diarrhea, and dry mouth may occur while use Zolpidem. To minimize risk of falls, remember to get up slowly when rising from a seated or lying position. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

Zolpidem may make we sleepy during day. Tell your doctor if we have daytime drowsiness. Your dose may need to be adjusted.

Remember that your doctor has prescribed Zolpidem because he or she has judged that benefit to we is greater than risk of side effects. Many people using Zolpidem do not have serious side effects.

Tell your doctor immediately if any of these unlikely but serious side effects occur:

Tell your doctor immediately if any of these rare but very serious side effects occur:

Rarely, after taking Zolpidem, people have gotten out of bed and driven vehicles while not fully awake ( " sleep-driving " ) . People have also sleepwalked, prepared/eaten food, made phone calls, or had sex while not fully awake. Often, these people do not remember these events. If you discover that we have experienced any of these events, tell your doctor immediately.

A very serious allergic reaction to Zolpidem is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include:

This isn't a complete list of possible side effects. If we notice other effects not listed above, contact your doctor or pharmacist.

Zolpidem: precautions

Before taking Zolpidem, tell your doctor or pharmacist if we are allergic to it; or if we have any other allergies.

Before using Zolpidem, tell your doctor or pharmacist your medical history, especially of:

Zolpidem may make you dizzy or drowsy; use caution engaging in activities requiring alertness such as driving or using machinery. Avoid alcoholic beverages because they may increase risk of Zolpidem's side effects.

Caution is advised when using Zolpidem in children because they may be more likely to experience hallucinations, especially if they have attention deficit disorder ( ADD ) or attention deficit hyperactivity disorder ( ADHD ) .

The elderly may be more sensitive to the effects of this drug, especially dizziness and excessive drowsiness.

Zolpidem should be used only when clearly needed during pregnancy. Infants born to mothers who have taken sedative/hypnotic drugs near time of delivery may have undesirable effects such as withdrawal symptoms. Discuss risks and benefits with your doctor.

A small amount of Zolpidem passes into breast milk. Consult your doctor before breast-feeding.

Zolpidem: interactions

Your healthcare professionals ( e. g. , doctor or pharmacist ) may already be aware of any possible drug interactions and may be monitoring you for it. Don't start, stop or change the dosage of any medicine before checking with them first.

Zolpidem shouldn't be used with following medication because a very serious interaction may occur while use Zolpidem:

If we are currently using any of these medications listed above, tell your doctor or pharmacist before starting Zolpidem.

Before using Zolpidem, tell your doctor or pharmacist of all prescription and nonprescription/herbal products we may use, especially of:

Tell your doctor or pharmacist if you also take drugs that cause drowsiness such as: certain antihistamines ( e. g. , diphenhydramine ) , anti-seizure drugs ( e. g. , carbamazepine ) , medicine for anxiety ( e. g. , alprazolam, diazepam ) , muscle relaxants, narcotic pain relievers ( e. g. , codeine ) , psychiatric medicines ( e. g. , chlorpromazine, risperidone, amitriptyline, trazodone ) .

Check labels on all your medicines ( e. g. , cough-and-cold products ) because they may contain ingredients that cause drowsiness. Ask your pharmacist about safe use of those products.

This document doesn't contain all possible interactions. Therefore, before using Zolpidem, tell your doctor or pharmacist of all products we use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

Zolpidem: overdose

If overdose of Zolpidem is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include slowed breathing or a deep sleep from which we cannot be awakened.

Zolpidem: notes

Don't share Zolpidem with others. It's against law.

Usually, insomnia is temporary and requires sleep medication only for a short time. If we require treatment for more than 2 weeks, laboratory and/or medical tests should be performed to find cause of your sleep problem.

As we get older, your sleep pattern may naturally change and your sleep may be interrupted several times during night. Consult your doctor or pharmacist for ways to improve your sleep without medication, such as avoiding caffeine and alcohol close to bedtime, avoiding daytime naps, and going to bed at the same time each night.

Zolpidem: missed dose

If you miss a dose Zolpidem, take it as soon as you remember if it is still near bedtime and you have trouble falling asleep. If it's already next day, resume your usual dosing schedule that night at bedtime. Don't double dose to catch up.

Zolpidem: storage

Store Zolpidem at room temperature between 59-77 degrees F ( 15-25 degrees C ) . Brief storage up to 86 degrees F ( 30 degrees C ) is permitted. Don't store in the bathroom. Keep all medicines away from children and pets.

Properly discard Zolpidem when it's expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

Zolpidem with US shipping

Journal Of Craniofacial Surgery Presents Update On " The Burned Child "

Burns in children are a complex and all-too common injury requiring coordinated care to achieve good medical, functional, and psychological outcomes. A thorough update in a wide range of areas affecting treatment and rehabilitation for " The Burned Child " is presented in a special topic section of July Journal of Craniofacial Surgery. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.

The special section is presented by American Association of Pediatric Plastic Surgery, together with the American Academy of Pediatrics Section on Plastic Surgery. " Unfortunately, burns are a relatively common clinical phenomenon encountered worldwide especially within the pediatric age group, " writes Section Editor Doctor Seth Thaller of University of Miami School of Medicine in an introductory editorial. " Acute management and long-term management and reconstruction can present a considerable clinical challenge to even most experienced practitioner in plastic surgery and to pediatric plastic surgeon. '

Written by leading experts in their fields, special study comprised of 29 papers present current perspectives on the many and complex aspects of care for children with burns, ranging from nonsurgical treatment of mild burns to acute medical care, surgical reconstruction, and long-term rehabilitation for severe burns. The special section provides a broad-ranging update for all surgeons involved in caring for the burned child.

Papers Address Infection Risk, Burn Coverage, and More

Burns are complex injuries that, when severe, can disrupt many body systems. This is especially true for children, in whom burns can easily involve a large percentage of body surface area. For example, several papers in special section address two interrelated issues: the risk of infection and challenge of providing coverage of skin areas destroyed by burns.

Even with modern medical care, infection is still leading cause of death after burns. Because burns disrupt the normal protective function of the skin, colonization with bacteria or other organisms can rapidly lead to widespread infection ( sepsis ) . Prompt surgery, the use of antimicrobial dressings, and skin grafts to replace burned skin are essential to controlling infection risk. New " bio-occlusive " and hybrid dressings have taken on an increasingly important role in management of children with burns.

Advances in cellular biology have led to new biomaterials, offering potentially valuable approaches to covering large areas of burned skin destroyed by burns. Promising techniques attempting to mimic the body's natural cellular repair mechanisms, disrupted after burn injuries, are being investigated as well.

Other papers in special section review approaches to reconstructive surgery after severe burns in children. Topics include special challenges of burns in specific areas for example, hands or face. Careful planning and repeated surgeries are needed to provide " resurfacing " of facial burns, avoiding complications related to contractures and scarring as the child grows.

After acute care and reconstructive surgery, psychological follow-up is an important part of care for burned children. Particularly after disfiguring burns of face, growing child's sense of identity can be disrupted, increasing risk of emotional and psychological problems. Long-term follow-up in form of psychological rehabilitation is essential, involving coordinated efforts by multidisciplinary burn care team, school, and family and child.

In an accompanying editorial, Dr. Mutaz B. Habal, Director of Tampa Bay Craniofacial Center in Tampa, Fla. and Editor-in-Chief of JCS, reflects on progress made in treatment and rehabilitation of burned children in his experience as a plastic surgeon, along with challenges still ahead. " Initially, patient outcome was measured by survival rate, but subsequently success is measured and evaluated by improvement of functional outcome of survivors, " Doctor Habal writes.

About The Journal of Craniofacial Surgery

The Journal of Craniofacial Surgery ( http: //www. jcraniofacialsurgery. com ) serves as a forum of communication for all those involved in craniofacial and maxillofacial surgery. Coverage ranges from practical aspects of craniofacial surgery to basic science that underlies surgical practice. Affiliates include 13 major specialty societies around world, including American Association of Pediatric Plastic Surgeons, the American Academy of Pediatrics Section of Pediatric Plastic Surgery, American Society of Craniofacial Surgeons, American Society of Maxillofacial Surgeons, Argentine Society of Plastic Surgery Section of Pediatric Plastic Surgery, the Asian Pacific Craniofacial Association, Brazilian Society of Craniofacial Surgeons, the European Society of Craniofacial Surgery, the International Society of Craniofacial Surgery, the Japanese Society of Craniofacial Surgery, the Korean Society of Craniofacial Surgery, the Thai Cleft and Craniofacial Association, and the World Craniofacial Foundation.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins ( http: //www. LWW. com ) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1, 500 books in more than 100 disciplines publishing under LWW brand, as well as content-based sites and online corporate and customer services. LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and pharmaceutical industry.

Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company with annual revenues ( 2007 ) of €3. 4 billion ( $4. 8 billion ) , maintains operations in over 33 countries across Europe, North America, and Asia Pacific and employs approximately 19, 500 people worldwide. Visit http: //www. wolterskluwer. com for information about our market positions, customers, brands, and organization.

Lippincott Williams & Wilkins 530 Walnut St. Philadelphia, PA 19106 United States http: //www. lww. com

Helpful healthcare tips by many topics wait you.